US 11007261
Compositions and methods of vaccination against dengue virus in children and young adults
granted A61KA61K2039/5254A61K2039/545
Quick answer
US patent 11007261 (Compositions and methods of vaccination against dengue virus in children and young adults) held by Takeda Vaccines, Inc. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 67
- CPC classes
- A61K, A61K2039/5254, A61K2039/545, A61K2039/55, A61K2039/70